GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Other Long Term Assets

GSK (MEX:GSK N) Other Long Term Assets : MXN260,920 Mil (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is GSK Other Long Term Assets?

GSK's other long-term assets for the quarter that ended in Dec. 2024 was MXN260,920 Mil.

GSK's quarterly other long-term assets increased from Jun. 2024 (MXN210,844 Mil) to Sep. 2024 (MXN243,160 Mil) and increased from Sep. 2024 (MXN243,160 Mil) to Dec. 2024 (MXN260,920 Mil).

GSK's annual other long-term assets declined from Dec. 2022 (MXN199,306 Mil) to Dec. 2023 (MXN189,617 Mil) but then increased from Dec. 2023 (MXN189,617 Mil) to Dec. 2024 (MXN260,920 Mil).

GSK Other Long Term Assets Historical Data

The historical data trend for GSK's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Other Long Term Assets Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 234,132.05 248,950.48 199,305.64 189,617.39 260,920.36

GSK Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 189,617.39 185,447.86 210,844.34 243,159.58 260,920.36

GSK Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Other Long Term Assets
Comparable Companies
LSE:AZN LLY JNJ ABBV OCSE:NOVO B XSWX:ROG MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 TSE:4578 XTER:BAYN BIIB TSE:4503
Traded in Other Exchanges
GLAXF:USA GSK:USA GSK1:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina
Address
79 New Oxford Street, London, GBR, WC1A 1DG
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines